ARTICLE | Clinical News
Celgene, Epizyme preclinical data
August 5, 2013 7:00 AM UTC
In a rat xenograft model of MLL-rearranged leukemia, continuous IV infusion of EPZ-5676 for 21 days led to dose-dependent tumor regression with no significant weight loss or signs of toxicity. Data we...